ESC 365 - Association between use of beta-blockers and mortality/morbidity in patients with heart failure with reduced, midrange or preserved ejection fraction and advanced chronic kidney disease

ESC Premium Access

Association between use of beta-blockers and mortality/morbidity in patients with heart failure with reduced, midrange or preserved ejection fraction and advanced chronic kidney disease

Session: Comorbidities in Heart Failure: What Could Be Done Better?

Topic: Pharmacotherapy

Speaker: Doctor E. Fu (Leiden, NL)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Edouard Fu

Leiden University Medical Center, Leiden (Netherlands (The))

0 follower

2 more presentations in this session

Myocardial iron depletion exacerbates end-stage heart failure by promoting adverse remodeling and worsening mitochondrial function

Speaker: Doctor H. Zhang (Edmonton, CA)

New-onset type 2 diabetes in heart failure: impact of heart failure and death versus ischemic events - a danish nationwide cohort study.

Speaker: Mrs B. Zareini (Copenhagen, DK)

Access the full session

Comorbidities in Heart Failure: What Could Be Done Better?

Speakers: Doctor E. Fu, Doctor H. Zhang, Mrs B. Zareini

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources